Peripheral venous disease
(UMLS:C0750166)
- UMLS ID:
- C0750166
- MeSH ID:
- N/A
Synonym(s)
1.
Peripheral venous disease
2.
VENOUS DISEASE PERIPHERAL
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | NuvaRing | FAERS: 24 | US FAERS | |
| 2 | apixaban | FAERS: 17 | US FAERS | |
| 3 | Rivaroxaban | FAERS: 7 | US FAERS | |
| 4 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 6 | US FAERS | |
| 5 | Testosterone | FAERS: 6 | US FAERS | |
| 6 | Everolimus | FAERS: 5 | US FAERS | |
| 7 | Finasteride | FAERS: 5 | US FAERS | |
| 8 | Pregabalin | FAERS: 4 | US FAERS | |
| 9 | teriflunomide | FAERS: 4 | US FAERS | |
| 10 | tofacitinib | FAERS: 4 | US FAERS | |
| 11 | Alendronate | FAERS: 3 | US FAERS | |
| 12 | Formoterol Fumarate | FAERS: 3 | US FAERS | |
| 13 | Glatiramer Acetate | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | PCI 32765 | FAERS: 3 | US FAERS | |
| 15 | Sitagliptin Phosphate | FAERS: 3 | US FAERS | |
| 16 | Amlodipine | FAERS: 2 | US FAERS | |
| 17 | Atorvastatin | FAERS: 2 | US FAERS | |
| 18 | Diclofenac | FAERS: 2 | US FAERS | |
| 19 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 20 | Ibuprofen | FAERS: 2 | US FAERS | |
| 21 | MDV 3100 | FAERS: 2 | US FAERS | |
| 22 | Metformin | FAERS: 2 | US FAERS | |
| 23 | Norgestrel | FAERS: 2 | US FAERS | |
| 24 | Raloxifene Hydrochloride | FAERS: 2 | US FAERS | |
| 25 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 26 | Sorafenib | FAERS: 2 | US FAERS | |
| 27 | Teriparatide | FAERS: 2 | US FAERS | |
| 28 | Thyroxine | FAERS: 2 | US FAERS | |
| 29 | Warfarin | FAERS: 2 | US FAERS | |
| 30 | aliskiren | FAERS: 2 | US FAERS | |
| 31 | macitentan | FAERS: 2 | US FAERS | |
| 32 | Aripiprazole | FAERS: 1 | US FAERS | |
| 33 | Buprenorphine | FAERS: 1 | US FAERS | |
| 34 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 35 | Clonidine | FAERS: 1 | US FAERS | |
| 36 | Dasatinib | FAERS: 1 | US FAERS | |
| 37 | Deferoxamine | FAERS: 1 | US FAERS | |
| 38 | Desogestrel | FAERS: 1 | US FAERS | |
| 39 | Dexlansoprazole | FAERS: 1 | US FAERS | |
| 40 | Diazepam | FAERS: 1 | US FAERS | |
| 41 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 42 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 43 | Felodipine | FAERS: 1 | US FAERS | |
| 44 | Fosamax plus D | FAERS: 1 | US FAERS | |
| 45 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 46 | Ibandronic Acid | FAERS: 1 | US FAERS | |
| 47 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 48 | Irbesartan | FAERS: 1 | US FAERS | |
| 49 | Lenalidomide | FAERS: 1 | US FAERS | |
| 50 | Liraglutide | FAERS: 1 | US FAERS | |
| 51 | Lisdexamfetamine Dimesylate | FAERS: 1 | US FAERS | |
| 52 | Medroxyprogesterone Acetate | FAERS: 1 | US FAERS | |
| 53 | Memantine | FAERS: 1 | US FAERS | |
| 54 | Metformin | FAERS: 1 | US FAERS | |
| 55 | Methylprednisolone | FAERS: 1 | US FAERS | |
| 56 | Metoprolol | FAERS: 1 | US FAERS | |
| 57 | Olanzapine | FAERS: 1 | US FAERS | |
| 58 | Ondansetron | FAERS: 1 | US FAERS | |
| 59 | Ondansetron | FAERS: 1 | US FAERS | |
| 60 | Piroxicam | FAERS: 1 | US FAERS | |
| 61 | Polidocanol | FAERS: 1 | US FAERS | |
| 62 | Prednisone | FAERS: 1 | US FAERS | |
| 63 | Qlaira | FAERS: 1 | US FAERS | |
| 64 | Ranolazine | FAERS: 1 | US FAERS | |
| 65 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 66 | Sevelamer | FAERS: 1 | US FAERS | |
| 67 | Tadalafil | FAERS: 1 | US FAERS | |
| 68 | Ticagrelor | FAERS: 1 | US FAERS | |
| 69 | Valproic Acid | FAERS: 1 | US FAERS | |
| 70 | Valproic Acid | FAERS: 1 | US FAERS | |
| 71 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 72 | ambrisentan | FAERS: 1 | US FAERS | |
| 73 | carfilzomib | FAERS: 1 | US FAERS | |
| 74 | empagliflozin | FAERS: 1 | US FAERS | |
| 75 | etonogestrel | FAERS: 1 | US FAERS | |
| 76 | gemcitabine | FAERS: 1 | US FAERS | |
| 77 | paricalcitol | FAERS: 1 | US FAERS | |
| 78 | pimavanserin | FAERS: 1 | US FAERS | |
| 79 | Clozapine | Canada Vigilance: 1 | Canada Vigilance | |
| 80 | Glycopyrrolate | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.